Sign In
Buy ATS
$28.85
-1.01 (-3.38%)
At Close: Jun 03, 2026
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment o
WILMINGTON, Del.--(BUSINESS WIRE)--The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blo
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
05:15pm, Sunday, 19'th May 2024
Late-Breaking Results From the Phase 2a COURSE Trial Illustrate Tezspire's Impact on COPD Exacerbations in Patients With a Broad Range of Eosinophil Levels THOUSAND OAKS, Calif. , May 19, 2024 /PRNews
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic
ATS to Participate in Deutsche Bank's Global Industrials, Materials & Building Products Conference
08:00am, Friday, 17'th May 2024
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Ryan McLeod, Chief Financial Officer will participate in Deutsche Bank
ATS to Participate in the Stifel 2024 Cross Sector Insight Conference
08:00am, Friday, 17'th May 2024
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Andrew Hider, Chief Executive Officer and Ryan McLeod, Chief Financial
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
04:35pm, Thursday, 16'th May 2024
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- When: May 17–22, 2024 Where: San Diego Convention Center (SDCC) | 111 Harbor Dr. San Diego, CA 92101
ATS Corporation (ATS) Q4 2024 Earnings Call Transcript
01:46pm, Thursday, 16'th May 2024
ATS Corporation (NYSE:ATS ) Q4 2024 Earnings Conference Call May 16, 2024 8:30 AM ET Company Participants David Galison - Head of Investor Relations Andrew Hider - Chief Executive Officer Ryan McLeod
ATS (ATS) Q4 Earnings and Revenues Top Estimates
12:16pm, Thursday, 16'th May 2024
ATS (ATS) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.54 per share a year ago.
ATS Reports Fourth Quarter and Annual 2024 Results
06:00am, Thursday, 16'th May 2024
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX and NYSE: ATS) (“ATS” or the “Company”) today reported its financial results for the three and twelve months ended March 31, 2024. All
AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
06:45pm, Wednesday, 15'th May 2024
THOUSAND OAKS, Calif. , May 15, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 1:00 p.m.
ATS To Acquire Packaging Machine Provider Paxiom
04:31pm, Wednesday, 15'th May 2024
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) a leading automation solutions provider, today announced it has entered into a definitive a
ATS to Participate in TD Cowen's 2nd Annual Sustainability Conference
05:00pm, Wednesday, 01'st May 2024
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Ryan McLeod, Chief Financial Officer will participate in TD Cowen's 2n
ATS To Host Fourth Quarter Earnings Call Thursday May 16, 2024, at 8:30 a.m. Eastern
06:36am, Wednesday, 01'st May 2024
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) will report its financial results for the fourth quarter ended March 31, 2024, before marke
ATS Announces C$163 Million Secondary Offering of Common Shares
04:11pm, Wednesday, 27'th Mar 2024
CAMBRIDGE, Ontario, March 27, 2024 (GLOBE NEWSWIRE) -- ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) has announced today that it has entered into an agreement with a fund man
